Stock-PR

Stock-PR Reporting

PGCX, PanGenex Corporation, PGCX.PK

FREE Daily Stock Alerts From Stock-PR.com

________________________________________

PGCX Through Licensing Agreement Expands Into The $600 Million Spirulla Market

John Stanton, Chairman of PanGenex said “Spirulla is considered a ’superfood,’ packed with 100% natural energy-boosting ingredients. We believe a move into the $600 million spirulla market is a major step toward sustaining long-term growth,” “Our goal is to reach sales of $2 million in our first year of production and increase exponentially as growing acreage is added and our additional products are brought to market.”

PanGenex plans to develop a variety of spirulla-infused heath products ideal for health-conscious consumers, aging baby-boomers, vegetarians and more. About PanGenex Corporation PanGenex pursues business opportunities in the $70 billion dollar nutraceutical and dietary supplement industry. With a focus on the cardiovascular health segment, PanGenex develops and markets sector-leading, patented or patent pending, condition-specific nutraceuticals and topical over-the-counter (OTC) drugs and personal care products.

PGCX has a strategic partnership (which it supports the joint development and commercialization of PGCX’s nutraceutical and healthcare products) with BulovaTech Labs, Inc., a wholly-owned subsidiary of Bulova Technologies Group Inc. that will accelerate the development of proprietary technologies and products, which will be marketed by PGCX under the PanGenex trademark.

PGCX has solidified plans to expand its retail product line with the addition of spirulla. Spirulla, a blue green algae, is an abundant and sustainable natural source of protein, essential fatty acids, vitamins, B12 and minerals that has been used as a dietary health supplement for centuries. Through a licensing agreement with Greenr U Corp., PanGenex has access to a state-of- the-art algae growing system to begin producing its own high-quality spirulla. The Company plans to incorporate spirulla into select product lines as well as develop an array of new, heart-healthy nutraceutical and dietary supplements featuring spirulla.

PGCX plans to develop a variety of spirulla-infused health products ideal for health-conscious consumers, aging baby-boomers, vegetarians and more.

PGCX initially expects to grow approximately 40,000 gallons of oil or 10,000 lbs of spirulla powders per acre per year. Dry powder spirulla sells for in excess of $50 per lb, while other specialized strains sell for in excess of $400 per lb. Other uses for algal oils and powder include protein enhancement products as part of the $27 billion sports nutrition market and in oil capsules as a replacement for certain types of liquid fish oil capsules. PGCX products will be marketed to health and whole food stores and through its various existing outlets.

More about PGCX at www.pangenex.com

________________________________________

________________________________________

******Advertisement******

********************************

Disclaimer:

Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more) Rule 17B requires disclosure of payment for investor relations.